GLP-1
-
Can GLP-1s lower some cancer risks? What new research suggestsCurrently, two generic versions of Ozempic and Wegovy are available for Canadians to purchase for patients who use it to treat diabetes or weight loss for a fraction of the cost.HealthJun 11
-
Novo Nordisk will slash Ozempic price for some, ‘aligning’ with genericsOzempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage dispensed, in some cases more than $450.HealthMay 26
-
Generic semaglutide to hit Canadian pharmacies this week at lower costHealth Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic and Wegovy — about three weeks ago.HealthMay 20
![]()
-
Canadians can now get Ozempic, Wegovy delivered to their homes. Here’s howPatients can receive the treatments at home for 'no additional cost' and will have the option of chatting with a pharmacist over the phone, Novo Nordisk said.CanadaMay 13
![]()
-
Health Canada approves country’s 1st generic version of OzempicThe injectable semaglutide medication is manufactured by Dr. Reddy's Laboratories in India and is approved for the once-weekly treatment of Type 2 diabetes in adults.HealthApr 28
![]()
-
U.S. FDA approves Eli Lilly’s GLP-1 oral weight-loss pillThe U.S. FDA said the drug was approved within 50 days of the company filing for approval, one of the fastest approval times for any drug.HealthApr 1
![]()
-
Could GLP-1 drugs help your mental health? New study finds a linkSemaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.HealthMar 20
![]()
-
Novo Nordisk says generic Ozempic, Wegovy will slow sales in CanadaNovo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.HealthFeb 4
![]()
-
Health Canada approves 1st GLP-1 daily pill. Here’s who can take itThe once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement Monday.CanadaJan 12
![]()
